Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Ironwood Pharmaceuticals (IRWD) Accumulated Depreciation & Amortization (2016 - 2025)

Ironwood Pharmaceuticals' Accumulated Depreciation & Amortization history spans 16 years, with the latest figure at $1.1 million for Q4 2025.

  • On a quarterly basis, Accumulated Depreciation & Amortization fell 8.33% to $1.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.1 million, a 8.33% decrease, with the full-year FY2025 number at $1.1 million, down 8.33% from a year prior.
  • Accumulated Depreciation & Amortization hit $1.1 million in Q4 2025 for Ironwood Pharmaceuticals, down from $1.2 million in the prior quarter.
  • Over the last five years, Accumulated Depreciation & Amortization for IRWD hit a ceiling of $1.5 million in Q4 2021 and a floor of $1.1 million in Q4 2025.
  • Historically, Accumulated Depreciation & Amortization has averaged $1.3 million across 5 years, with a median of $1.2 million in 2023.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: plummeted 34.78% in 2021 and later changed 0.0% in 2024.
  • Tracing IRWD's Accumulated Depreciation & Amortization over 5 years: stood at $1.5 million in 2021, then decreased by 6.67% to $1.4 million in 2022, then dropped by 14.29% to $1.2 million in 2023, then changed by 0.0% to $1.2 million in 2024, then decreased by 8.33% to $1.1 million in 2025.
  • Business Quant data shows Accumulated Depreciation & Amortization for IRWD at $1.1 million in Q4 2025, $1.2 million in Q4 2024, and $1.2 million in Q4 2023.